Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) Debt to Equity (2016 - 2023)

Marimed (MRMD) has disclosed Debt to Equity for 12 consecutive years, with $0.28 as the latest value for Q3 2023.

  • Quarterly Debt to Equity changed N/A to $0.28 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $0.28 through Sep 2023, changed N/A year-over-year, with the annual reading at $0.48 for FY2021, 67.47% down from the prior year.
  • Debt to Equity for Q3 2023 was $0.28 at Marimed, down from $0.3 in the prior quarter.
  • The five-year high for Debt to Equity was $153.66 in Q3 2020, with the low at -$2.84 in Q2 2020.
  • Average Debt to Equity over 5 years is $9.59, with a median of $0.15 recorded in 2021.
  • Peak annual rise in Debt to Equity hit 3060128.43% in 2020, while the deepest fall reached 304992.6% in 2020.
  • Over 5 years, Debt to Equity stood at $0.28 in 2019, then soared by 427.16% to $1.46 in 2020, then plummeted by 67.47% to $0.48 in 2021, then tumbled by 99.78% to $0.0 in 2022, then soared by 26589.78% to $0.28 in 2023.
  • According to Business Quant data, Debt to Equity over the past three periods came in at $0.28, $0.3, and $0.37 for Q3 2023, Q2 2023, and Q1 2023 respectively.